Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Laboratories up in a weak market on positive growth view

** Shares of Divi's Laboratories  DIVI.NS  rise as much as
1.38% to 2,829.95 rupees in a weak market
    ** DIVI among top gainers in Nifty 50  .NSEI  and Nifty
Pharma  .NIPHARMA , which are down 1.06% and 0.41%, respectively
    ** Easing cost pressures indicate improved profitability
going forward, says Motilal Oswal after meeting with co's
management
    ** Relaxation in power, fuel and freight cost as well as
expected demand recovery for API products to aid further growth,
says brokerage
    ** Adds DIVI could post 15% annual average earnings growth
over FY23-FY25 
    ** Brokerage, however, finds valuations expensive and
maintains "neutral" rating on DIVI
    ** Four of 22 analysts tracking DIVI maintain "buy", nine
suggest "sell" and nine recommend "hold"; median PT is 2,820
rupees

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))

Recent news on Divi's Laboratories

See all news